SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001564590-21-041180
Filing Date
2021-08-05
Accepted
2021-08-05 07:36:09
Documents
14
Period of Report
2021-08-05
Items
Item 2.02: Results of Operations and Financial Condition
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K dyn-8k_20210805.htm   iXBRL 8-K 42596
2 EX-99.1 dyn-ex991_6.htm EX-99.1 88200
3 GRAPHIC ggztuetbat05000001.jpg GRAPHIC 34126
  Complete submission text file 0001564590-21-041180.txt   316023

Data Files

Seq Description Document Type Size
4 XBRL TAXONOMY EXTENSION SCHEMA dyn-20210805.xsd EX-101.SCH 5678
5 XBRL TAXONOMY EXTENSION LABEL LINKBASE dyn-20210805_lab.xml EX-101.LAB 19323
6 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE dyn-20210805_pre.xml EX-101.PRE 11478
7 EXTRACTED XBRL INSTANCE DOCUMENT dyn-8k_20210805_htm.xml XML 3539
Mailing Address 830 WINTER STREET WALTHAM MA 02451
Business Address 830 WINTER STREET WALTHAM MA 02451 (781) 786-8230
Dyne Therapeutics, Inc. (Filer) CIK: 0001818794 (see all company filings)

IRS No.: 364883909 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-39509 | Film No.: 211146349
SIC: 2834 Pharmaceutical Preparations